Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
Use this CRL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRL SEC filings page. Lician reads the product cache first so this HTML stays unique to Charles River Laboratories even when a live quote feed is slow.
Latest cached year on this hub. Full CRL income, balance, and cash tables.